R932333
C-932333-002
Phase 2 small_molecule completed
Quick answer
R932333 for Lupus Erythematosus, Discoid is a Phase 2 program (small_molecule) at RIGEL PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RIGEL PHARMACEUTICALS INC
- Indication
- Lupus Erythematosus, Discoid
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed